Gregory Pugnet

Summary

Country: France

Publications

  1. doi request reprint Is Statin Exposure Associated with Occurrence or Better Outcome in Giant Cell Arteritis? Results from a French Population-based Study
    Gregory Pugnet
    From the Faculté de Médecine, and the Laboratoire de Pharmacologie Médicale et Clinique, Université de Toulouse III INSERM, UMR1027 Service de Médecine Interne, and the Service de Pharmacologie Clinique, Centre Hospitalier Universitaire CHU Toulouse Caisse Nationale d Assurance Maladie des Travailleurs Salariés, Service Médical Midi Pyrénées, Toulouse, France G Pugnet, MD L Sailler, MD, PhD, Universite de Toulouse III, INSERM, UMR1027, Service de Medecine Interne, CHU Toulouse R Bourrel, MD, Caisse nationale d assurance maladie des travailleurs salariés, Service Médical Midi Pyrénées J L Montastruc, MD, PhD M Lapeyre Mestre, MD, PhD, Universite de Toulouse III, INSERM, UMR1027, Laboratoire de Pharmacologie Medicale et Clinique, Universite de Toulouse III, Service de Pharmacologie Clinique, CHU Toulouse
    J Rheumatol 42:316-22. 2015
  2. ncbi request reprint Progressive multifocal encephalopathy after cyclophosphamide in granulomatosis with polyangiitis (Wegener) patients: case report and review of literature
    G Pugnet
    Service de Médecine Interne salle Le Tallec, CHU Toulouse Purpan, Toulouse, France
    Clin Exp Rheumatol 31:S62-4. 2013

Collaborators

Detail Information

Publications2

  1. doi request reprint Is Statin Exposure Associated with Occurrence or Better Outcome in Giant Cell Arteritis? Results from a French Population-based Study
    Gregory Pugnet
    From the Faculté de Médecine, and the Laboratoire de Pharmacologie Médicale et Clinique, Université de Toulouse III INSERM, UMR1027 Service de Médecine Interne, and the Service de Pharmacologie Clinique, Centre Hospitalier Universitaire CHU Toulouse Caisse Nationale d Assurance Maladie des Travailleurs Salariés, Service Médical Midi Pyrénées, Toulouse, France G Pugnet, MD L Sailler, MD, PhD, Universite de Toulouse III, INSERM, UMR1027, Service de Medecine Interne, CHU Toulouse R Bourrel, MD, Caisse nationale d assurance maladie des travailleurs salariés, Service Médical Midi Pyrénées J L Montastruc, MD, PhD M Lapeyre Mestre, MD, PhD, Universite de Toulouse III, INSERM, UMR1027, Laboratoire de Pharmacologie Medicale et Clinique, Universite de Toulouse III, Service de Pharmacologie Clinique, CHU Toulouse
    J Rheumatol 42:316-22. 2015
    ..To investigate the potential association between statin use and giant cell arteritis (GCA) course...
  2. ncbi request reprint Progressive multifocal encephalopathy after cyclophosphamide in granulomatosis with polyangiitis (Wegener) patients: case report and review of literature
    G Pugnet
    Service de Médecine Interne salle Le Tallec, CHU Toulouse Purpan, Toulouse, France
    Clin Exp Rheumatol 31:S62-4. 2013
    ..PML should be strongly suspected whenever unusual central neurological manifestations appear in this context. No effective treatment is available, but immunosuppressants should be discontinued if possible...